HRS-8829
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HRS-8829, covering 2025-07-24 to 2025-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of HRS-8829 [Phase 1]